GWPH - Stoke Therapeutics: A Preclinical Biopharma With A Multibillion Dollar Market Cap
- Stoke Therapeutics is working in cutting edge science, however it is in early stages.
- It already has a very high valuation.
- This will take a few more years to mature as an investment for retail investors.
For further details see:
Stoke Therapeutics: A Preclinical Biopharma With A Multibillion Dollar Market Cap